2025-07-13 - Analysis Report
Okay, here's a report analyzing Hims & Hers Health Inc (HIMS), formatted in English, with a focus on summarizing the provided data and adding concise analysis:

## Hims & Hers Health Inc (HIMS) Stock Analysis

**Company Overview:** Hims & Hers Health Inc is a telehealth company that offers personalized health and wellness solutions directly to consumers.

### 1.  Performance vs. S&P 500 (VOO)

*   **Cumulative Return (HIMS):** 181.13%
*   **Cumulative Return (VOO):** 64.05%
*   **Spread (HIMS - VOO):**
    *   Current: 120.6
    *   Max: 288.9
    *   Min: -88.4
    *   Relative Spread: 55.4

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO). The current spread of 120.6 indicates substantial outperformance. A Relative Spread of 55.4 suggests the current spread is somewhat in the middle range of its historical deviations from the benchmark.

**Alpha, Beta Analysis Table:**

| Year       | CAGR     | MDD    | Alpha    | Beta   | Cap(B) |
|------------|----------|--------|----------|--------|--------|
| 2019-2021  | -46.0%   | 51.0%  | -84.0%   | -0.0   | 1.5    |
| 2020-2022  | -15.0%   | 72.1%  | -17.0%   | -0.0   | 1.4    |
| 2021-2023  | -51.0%   | 72.1%  | -69.0%   | -0.1   | 2.0    |
| 2022-2024  | 127.0%   | 78.4%  | 101.0%   | -0.1   | 5.4    |
| 2023-2025  | 176.0%   | 78.4%  | 129.0%   | -0.1   | 10.7   |

**Analysis:**

*   **CAGR:** Fluctuates significantly, showing periods of substantial decline followed by strong growth.
*   **MDD:** High Maximum Drawdown values indicate significant risk and volatility.
*   **Alpha:** Generally negative in earlier periods but turns strongly positive in recent years, suggesting improved performance relative to the market.
*   **Beta:** Consistently near zero, suggesting little correlation with the overall market.
*   **Cap:** Market capitalization has grown significantly, particularly in the most recent period.

### 2. Recent Price Action

*   **Current Price:** 47.89
*   **Previous Close:** 50.27
*   **Change:** -4.73 (-4.73)
*   **5-Day Moving Average:** 49.36
*   **20-Day Moving Average:** 50.94
*   **60-Day Moving Average:** 48.50

**Analysis:** The stock price has recently decreased, closing significantly lower than the previous day. It is trading below its 5-day and 20-day moving averages, suggesting short-term bearish momentum. However, the price is still near the 60-day moving average.

### 3.  Technical Indicators & Outlook

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 31.14 (Approaching Oversold)
*   **PPO:** -0.23 (Negative Momentum)
*   **Hybrid Signal:** cash_69%_Sell 1.2% of holdings (15 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Spread Change:** 1.3 (Positive - Short-Term Increase)
*   **Expected Return:** -16.2% (Over 2 years vs. S&P 500)

**Analysis:** The MRI indicates a low-risk environment. The RSI is approaching oversold territory, which could indicate a potential buying opportunity. The negative PPO suggests downward price momentum. The hybrid signal recommends a cautious stance, suggesting selling a small portion of holdings. The 20-day relative spread change is positive, but expected return is negative. The significant price change compared to the previous close (-4.73) reflects considerable downward pressure.

### 4. Recent News & Significant Events

*   **[2025-07-11]:** Major business developments, regulatory changes, or market events are impacting HIMS.
*   **[2025-07-13]:** Analysts are discussing HIMS's recent performance in the context of industry trends and global economic factors.
*   **[2025-07-10]:** HIMS stock is showing notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-12]:** Market experts highlight both risks and opportunities, advising monitoring recent news and company announcements.

**Analysis:** Recent news suggests heightened volatility and the need to carefully monitor company-specific developments and analyst commentary.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-05-05 | 0.22 | 0.59 B$     |
| 2024-11-04 | 0.35 | 0.40 B$     |
| 2024-08-05 | 0.06 | 0.32 B$     |
| 2024-05-06 | 0.05 | 0.28 B$     |
| 2025-05-05 | 0.05 | 0.28 B$     |

**Analysis:**
*   **EPS:** Shows a fluctuating trend, with a recent notable increase followed by volatility.
*   **Revenue:** Demonstrates consistent growth over the quarters.
*   **Recent Growth:** Revenue has shown significant improvement while earnings per share have remained volatile.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $0.59B    | 73.50%        |
| 2024-12-31 | $0.48B    | 76.81%        |
| 2024-09-30 | $0.40B    | 79.16%        |
| 2024-06-30 | $0.32B    | 81.30%        |
| 2024-03-31 | $0.28B    | 82.36%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-03-31 | $0.55B    | 9.01%     |
| 2024-12-31 | $0.48B    | 5.46%     |
| 2024-09-30 | $0.44B    | 17.18%    |
| 2024-06-30 | $0.36B    | 3.67%     |
| 2024-03-31 | $0.34B    | 3.23%     |

**Analysis:**

*   **Revenue:** Revenue has grown consistently over the past few quarters, indicating strong business expansion.
*   **Profit Margin:** Profit margins have been decreasing, suggesting rising costs or pricing pressures.
*   **Equity:** Equity has increased steadily, reflecting asset growth and reinvestment.
*   **ROE:** ROE fluctuates, reflecting changes in profitability relative to equity. A recent decrease could be concerning.

### 7. Summary Analysis

Hims & Hers Health Inc (HIMS) has shown strong outperformance compared to the S&P 500, and has experienced significant revenue growth and increased market capitalization. However, it exhibits high volatility. Recent performance is mixed, with a significant drop in stock price and a negative expected return. The company's financial health is a mixed bag, with decreasing profit margins and ROE alongside revenue growth. News reports indicate volatility and the importance of monitoring company-specific events.

**Overall Recommendation:** Given the recent price drop, oversold RSI, and positive revenue growth, HIMS might present a potential buying opportunity for long-term investors who can tolerate high volatility. However, the negative expected return and decreasing profit margins should be carefully considered. Monitoring future earnings reports and company announcements is crucial. The hybrid signal suggesting selling a small portion of holdings might be a conservative approach.
